Human Molecular Genetics, 1999, Vol. 8, No. 7 1253-1262
© 1999 Oxford University Press
A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression
1Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany, 2Institut für Zellbiochemie und Klinische Neurobiologie, Universitätskrankenhaus Eppendorf, Martinistraße 52, 20246 Hamburg, Germany and 3Institute of Biology and Medical Genetics, Second Medical School, Charles University, V uvalu 84, 15006 Prague, Czech Republic
A systematic search for expressed sequences in the human Xq28 region resulted in the isolation of 8.5 kb large contigs of human and murine cDNAs with no apparent conserved open reading frames. These cDNAs were found to be derived from the 3"-untranslated region (3"-UTR) of the methyl-CpG-binding protein 2 gene (MeCP2). This long 3"-UTR is part of an alternatively polyadenylated, 10.1 kb MeCP2 transcript which is differentially expressed in human brain and other tissues. RNA in situ hybridization to sections of mouse embryo and adult tissues of an Mecp2 3"-UTR probe showed ubiquitous low level expression in early organogenesis and enhanced expression in the hippocampus during formation of the differentiated brain. Sequence comparison between the human and mouse homologues revealed several blocks of very high conservation separated by less conserved sequences. Additional support for a domain-like conservation pattern of the long 3"-UTR of the MeCP2 gene was obtained by examining conservation in the chimpanzee, orangutan, macaque, hamster, rat and kangaroo. The minimum free energy distribution for the predicted RNA secondary structure was very similar in human and mouse sequences. In particular, the conserved blocks were predicted to be of high minimum free energy, which suggests weak secondary structure with respect to RNA folding. The fact that both the sequence and predicted secondary structure have been highly conserved during evolution suggests that both the primary sequence and the three-dimensional structure of the 3"-UTR may be important for its function in post-transcriptional regulation of MeCP2 expression.
a To whom correspondence should be addressed. Tel: +49 6221 424742; Fax: +49 6221 423454; Email: a.poustka{at}dkfz-heidelberg.de
DDBJ/EMBL/GenBank accession nos AJ132914–AJ132924.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Singh, A. Saxena, J. Christodoulou, and D. Ravine MECP2 genomic structure and function: insights from ENCODE Nucleic Acids Res., November 1, 2008; 36(19): 6035 - 6047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Namihira, J. Kohyama, M. Abematsu, and K. Nakashima Epigenetic mechanisms regulating fate specification of neural stem cells Phil Trans R Soc B, June 27, 2008; 363(1500): 2099 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Samaco, J. D. Fryer, J. Ren, S. Fyffe, H.-T. Chao, Y. Sun, J. J. Greer, H. Y. Zoghbi, and J. L. Neul A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome Hum. Mol. Genet., June 15, 2008; 17(12): 1718 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Forest, R. Nishikawa, H. Kobayashi, A. Parton, C. J. Bayne, and D. W. Barnes RNA expression in a cartilaginous fish cell line reveals ancient 3' noncoding regions highly conserved in vertebrates PNAS, January 23, 2007; 104(4): 1224 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu and U. Francke Identification of cis-regulatory elements for MECP2 expression Hum. Mol. Genet., June 1, 2006; 15(11): 1769 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Adachi, E. W. Keefer, and F. S. Jones A segment of the Mecp2 promoter is sufficient to drive expression in neurons Hum. Mol. Genet., December 1, 2005; 14(23): 3709 - 3722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kishi and J. D. Macklis Dissecting MECP2 Function in the Central Nervous System J Child Neurol, September 1, 2005; 20(9): 753 - 759. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, September 1, 2005; 20(9): 768 - 778. [Abstract] [PDF]
|
|
|
|
|
|
N. Kishi and J. D. Macklis Dissecting MECP2 Function in the Central Nervous System J Child Neurol, August 1, 2005; 20(8): 753 - 759. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, August 1, 2005; 20(8): 768 - 778. [Abstract] [PDF]
|
|
|
|
 |
|
 L S Weaving, C J Ellaway, J Gecz, and J Christodoulou Rett syndrome: clinical review and genetic update J. Med. Genet., January 1, 2005; 42(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Collins, J. M. Levenson, A. P. Vilaythong, R. Richman, D. L. Armstrong, J. L. Noebels, J. David Sweatt, and H. Y. Zoghbi Mild overexpression of MeCP2 causes a progressive neurological disorder in mice Hum. Mol. Genet., November 1, 2004; 13(21): 2679 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Braunschweig, T. Simcox, R. C. Samaco, and J. M. LaSalle X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain Hum. Mol. Genet., June 15, 2004; 13(12): 1275 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Luikenhuis, E. Giacometti, C. F. Beard, and R. Jaenisch Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice PNAS, April 20, 2004; 101(16): 6033 - 6038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kriaucionis and A. Bird The major form of MeCP2 has a novel N-terminus generated by alternative splicing Nucleic Acids Res., March 19, 2004; 32(5): 1818 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Samaco, R. P. Nagarajan, D. Braunschweig, and J. M. LaSalle Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum. Mol. Genet., March 15, 2004; 13(6): 629 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Esfandiari, R. Green, R. F. Cotterman, I. P. Pogribny, S. J. James, and J. W. Miller Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver Carcinogenesis, December 1, 2003; 24(12): 1935 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Gill, J P Cheadle, J Maynard, N Fleming, S Whatley, T Cranston, E M Thompson, H Leonard, M Davis, J Christodoulou, et al. Mutation analysis in the MECP2 gene and genetic counselling for Rett syndrome J. Med. Genet., May 1, 2003; 40(5): 380 - 384. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kimura and K. Shiota Methyl-CpG-binding Protein, MeCP2, Is a Target Molecule for Maintenance DNA Methyltransferase, Dnmt1 J. Biol. Chem., February 7, 2003; 278(7): 4806 - 4812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Akbarian The Neurobiology of Rett Syndrome Neuroscientist, February 1, 2003; 9(1): 57 - 63. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Iseli, B. J. Stevenson, S. J. de Souza, H. B. Samaia, A. A. Camargo, K. H. Buetow, R. L. Strausberg, A. J.G. Simpson, P. Bucher, and C. V. Jongeneel Long-Range Heterogeneity at the 3' Ends of Human mRNAs Genome Res., July 1, 2002; 12(7): 1068 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Shahbazian, B. Antalffy, D. L. Armstrong, and H. Y. Zoghbi Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation Hum. Mol. Genet., January 1, 2002; 11(2): 115 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. LaSalle, J. Goldstine, D. Balmer, and C. M. Greco Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry Hum. Mol. Genet., August 1, 2001; 10(17): 1729 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Couvert, T. Bienvenu, C. Aquaviva, K. Poirier, C. Moraine, C. Gendrot, A. Verloes, C. Andres, A. C. Le Fevre, I. Souville, et al. MECP2 is highly mutated in X-linked mental retardation Hum. Mol. Genet., April 1, 2001; 10(9): 941 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Webb and F. Latif Rett syndrome and the MECP2 gene J. Med. Genet., April 1, 2001; 38(4): 217 - 223. [Full Text]
|
|
|
|
|
|
T. M. Yusufzai and A. P. Wolffe Functional consequences of Rett syndrome mutations on human MeCP2 Nucleic Acids Res., November 1, 2000; 28(21): 4172 - 4179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dragich, I. Houwink-Manville, and C. Schanen Rett syndrome: a surprising result of mutation in MECP2 Hum. Mol. Genet., October 1, 2000; 9(16): 2365 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Kaufmann and H. W. Moser Dendritic Anomalies in Disorders Associated with Mental Retardation Cereb Cortex, October 1, 2000; 10(10): 981 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K OBATA, T MATSUISHI, Y YAMASHITA, T FUKUDA, K KUWAJIMA, I HORIUCHI, S NAGAMITSU, R IWANAGA, A KIMURA, I OMORI, et al. Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome J. Med. Genet., August 1, 2000; 37(8): 608 - 610. [Full Text]
|
|
|
|
|
|
P. Huppke, F. Laccone, N. Kramer, W. Engel, and F. Hanefeld Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients Hum. Mol. Genet., May 22, 2000; 9(9): 1369 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Cheadle, H. Gill, N. Fleming, J. Maynard, A. Kerr, H. Leonard, M. Krawczak, D. N. Cooper, S. Lynch, N. Thomas, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location Hum. Mol. Genet., April 12, 2000; 9(7): 1119 - 1129. [Abstract] [Full Text] [PDF]
|
|